PFKFB3 and colorectal carcinoma: An enzyme that regulates glycolysis, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), is a target for cancer chemotherapy, for the small-molecule inhibitors of PFKFB3 reduce growth of CRC cells [8].